Literature DB >> 25424449

Evaluation of Giardia duodenalis viability after metronidazole treatment by flow cytometry.

Joana Barbosa1, Acácio Gonçalves Rodrigues1, Maria José Pérez2, Cidália Pina-Vaz1.   

Abstract

Giardia duodenalis (syn. lamblia; syn. intestinalis) susceptibility testing is not routinely performed because the classical culture methods are very time-consuming and laborious. We developed a novel flow cytometry (FC) assay to evaluate the susceptibility of G. duodenalis trophozoites to metronidazole (MTZ). Different concentrations of MTZ were added to cultures of trophozoites (10 5 /mL) and the cultures were incubated for different periods. The 50% inhibitory concentration was calculated and propidium iodide (PI) was used to quantify the number of dead cells. After treatment, PI-positive trophozoites increased with increasing drug concentration and exposure time. An excellent correlation was found between FC and the classical method. A novel, accurate and reliable method is now available to evaluate G. duodenalis viability.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25424449      PMCID: PMC4325610          DOI: 10.1590/0074-0276140267

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  14 in total

1.  Safe susceptibility testing of Mycobacterium tuberculosis by flow cytometry with the fluorescent nucleic acid stain SYTO 16.

Authors:  C Pina-Vaz; S Costa-de-Oliveira; A G Rodrigues
Journal:  J Med Microbiol       Date:  2005-01       Impact factor: 2.472

2.  Comparison of two probes for testing susceptibilities of pathogenic yeasts to voriconazole, itraconazole, and caspofungin by flow cytometry.

Authors:  Cidália Pina-Vaz; Sofia Costa-de-Oliveira; Acácio G Rodrigues; Ana Espinel-Ingroff
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  A new method for assessing metronidazole susceptibility of Giardia lamblia trophozoites.

Authors:  M C Sousa; J Poiares-Da-Silva
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

4.  Cytometric approach for a rapid evaluation of susceptibility of Candida strains to antifungals.

Authors:  C Pina-Vaz; F Sansonetty; A G Rodrigues; S Costa-Oliveira; C Tavares; J Martinez-de-Oliveira
Journal:  Clin Microbiol Infect       Date:  2001-11       Impact factor: 8.067

5.  An integrated microfludic device for culturing and screening of Giardia lamblia.

Authors:  Guo-Xia Zheng; Xue-Mei Zhang; Yu-Suo Yang; Shu-Rui Zeng; Jun-Feng Wei; Yun-Hua Wang; Ya-Jie Li
Journal:  Exp Parasitol       Date:  2013-12-06       Impact factor: 2.011

6.  Optimization of a flow cytometry protocol for detection and viability assessment of Giardia lamblia.

Authors:  Joana Barbosa; Sofia Costa-de-Oliveira; Acácio Gonçalves Rodrigues; Cidália Pina-Vaz
Journal:  Travel Med Infect Dis       Date:  2008-03-04       Impact factor: 6.211

7.  A new quantitative in vitro microculture method for Giardia duodenalis trophozoites.

Authors:  Ely Bénéré; Raquel Andreia Inocêncio da Luz; Marieke Vermeersch; Paul Cos; Louis Maes
Journal:  J Microbiol Methods       Date:  2007-08-15       Impact factor: 2.363

8.  Effect of metronidazole analogues on Giardia lamblia cultures.

Authors:  Haendel G N O Busatti; Andrea E D Vieira; João C Viana; Hugo E Silva; Elaine M Souza-Fagundes; Olindo A Martins-Filho; Ricardo J Alves; Maria A Gomes
Journal:  Parasitol Res       Date:  2007-09-30       Impact factor: 2.289

9.  Isolation, excystation and axenization of Giardia lamblia isolates: in vitro susceptibility to metronidazole and albendazole.

Authors:  Agostinho Cruz; M Isaura Sousa; Zaida Azeredo; Emilia Leite; J C Figueiredo de Sousa; Miguel Cabral
Journal:  J Antimicrob Chemother       Date:  2003-03-13       Impact factor: 5.790

10.  Flowcytometric assessment of the effect of drugs on Giardia lamblia trophozoites in vitro.

Authors:  Harpreet Sandhu; Ramesh Chander Mahajan; Nirmal Kumar Ganguly
Journal:  Mol Cell Biochem       Date:  2004-10       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.